 |
6-[(3S,4S-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imadazo[1,5-a]pyrazin-8-one |
|---|---|
| Trade Name | |
| Orphan Indication | Sickle cell anemia |
| USA Market Approval | USA |
| USA Designation Date | 2017-01-31 00:00:00 |
| Sponsor | Imara Inc.;700 Technology Square, 3rd Floor;Cambridge, Massachusetts, 02139 |
Related Access Program